
Featuring : Mark L. Bagarazzi, MD Chief Medical Officer
latest videos

Featuring : Craig Dees, PhD, Chief Executive Officer, Provectus Pharmaceuticals Inc., (PVCT.OB)
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.

Featuring : Thomas Davis, MD, Senior Vice President and Chief Medical Officer, Celldex, Inc. (NASDAQ:CLDX)
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.

Featuring : Manish Singh, PhD, President & Chief Executive Officer, ImmunoCellular Therapeutics, Ltd., (OTC:IMUC.OB)
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.

Featuring : Marnix L Bosch, PhD, Chief Technical Officer, Northwest Bioterapeutics, Inc., (OTC:NWBO).
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.

Featuring : Timothy A. Wurst, MBA, Vice President for Clinical Research and Regulatory Affairs, TVAX Biomedical, LLC.
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.

Featuring : Frederick M. Miesowicz, PhD, Chief Operating Officer, Argos Therapeutics.
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.

Featuring : Carlos F. Santos, PhD, Vice President for Regulatory Affairs and Clinical Development, Biovest International Inc. (PINK:BVTI).
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.

Featuring : Dr. Neil Frazer, Vice President Product Development and Clinical Affairs, Prima BioMed Ltd. (ASX:PRR).
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
BioSante Presentation at Cancer Immunotherapy Conference
Featuring : M. Stephen Simes, Vice-Chairman, President and Chief Executive Officer, BioSante
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.